Endocrine Abstracts

The aim of the study was to compare ATPIII and IDF criteria for metabolic syndrome in diabetes mellitus type 2 subjects.

Two hundred and seventy-seven participants were included, 177 women 60.43±8.06 years and 100 men aged 56.35±9.58 years. Group A: metabolic syndrome by ATPIII; group B metabolic syndrome by IDF.

Following laboratory and antropometric measurements were done: total cholesterol, triglycerides, LDL- and HDL cholesterol, fasting plasma glucose, body height, body weight, waist circumference, arterial blood pressure.

We found fewer subjects with metabolic syndrome in group A compared to group B (65% versus 68%). Group B had more women (78%) than group A (71%). In males, it was vice versa (group A 54% versus group B 51%).

Male subjects of group A had statistically significant (P<0.05) smaller waist circumference and mean daily glucose levels compared to male subjects in group B (101±11.54 vs 104±7.64 and 12.89±4.36 vs 14.52±3.94, respectively). Group A had more atherogenic lipid profile (TG 2.76±1.79 in males and 2.59±1.99 females, HDL 1.08±0.13 in males and 1.22±0.3 in females, LDL/HDL 3.71±1.43 in males and 3.27±0.89 in females) compared to group B (TG 2.64±2.01 in males and 2.63±1.96 in females, HDL 1.14±0.33 in males and 1.24±0.31 in females, LDL/HDL 3.42±1.15 in males and 3.23±0.92 in females), but without statistic significance. We did not find statistically significant difference in arterial blood pressure values between two groups (P>0.05).

The use of ATP III and IDF criteria did not show statistically significant difference in detecting metabolic syndrome in all diabetes mellitus type 2 participants (χ²=0.659; P>0.05). There was not any statistically significant difference between women and men (χ²=2.16; P>0.05 and χ²=0.08; P>0.05, respectively).